Eight researchers at Fred Hutch Cancer Center will receive a total of $975,000 for research projects as part of Fred Hutch’s Evergreen Fund, an internal grant program designed to advance translational discoveries to a commercially viable stage.
The Advanced Research Projects Agency for Health, an agency within the U.S. Department of Health and Human Services, announced the teams for the Treating Hereditary Rare Diseases with In Vivo Precision Genetic Medicines (THRIVE) program—a critical investment toward bringing new treatments to patients faster and curing rare genetic pediatric diseases.Â
